Published in Eur J Pediatr on March 03, 2007
Varicella vaccination in Europe - taking the practical approach. BMC Med (2009) 1.63
A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008. J Gen Virol (2010) 1.49
A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine. PLoS One (2011) 1.10
Immune modulation during latent herpesvirus infection. Immunol Rev (2012) 0.96
Herpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine. PLoS One (2010) 0.92
Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bull World Health Organ (2014) 0.91
Vaccination coverage among adolescents and risk factors associated with incomplete immunization. Eur J Pediatr (2011) 0.90
The humanistic, economic and societal burden of herpes zoster in Europe: a critical review. BMC Public Health (2015) 0.87
Successes and challenges in varicella vaccine. Ther Adv Vaccines (2014) 0.86
Should the UK introduce varicella vaccine? Arch Dis Child (2007) 0.84
Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population. BMC Infect Dis (2012) 0.81
Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial. BMC Pediatr (2016) 0.75
Computational modeling of interventions and protective thresholds to prevent disease transmission in deploying populations. Comput Math Methods Med (2014) 0.75
Prevention of Herpes Zoster and its complications: from clinical evidence to real life experience. Hum Vaccin Immunother (2016) 0.75
Retracted Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet (1998) 36.93
THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med (1965) 10.85
Outbreak of varicella at a day-care center despite vaccination. N Engl J Med (2002) 4.19
Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med (2005) 3.83
Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data. BMJ (2001) 3.81
Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA (2002) 3.59
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect (2001) 2.98
Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N Engl J Med (1984) 2.93
Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J (2004) 2.69
Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet (1994) 2.43
Varicella vaccine--are two doses better than one? N Engl J Med (2002) 2.40
Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet (2002) 2.34
Varicella in children with cancer: Seventy-seven cases. Pediatrics (1975) 2.29
The postmarketing safety profile of varicella vaccine. Vaccine (2000) 2.18
Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine (2002) 2.12
Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol (2004) 1.85
Economic evaluations of varicella vaccination programmes: a review of the literature. Pharmacoeconomics (2003) 1.85
Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis (2000) 1.76
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis (2002) 1.58
The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health (2005) 1.57
Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics (2004) 1.48
Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet (1989) 1.48
Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol (2003) 1.48
The utility of serologic testing for varicella in an adolescent population. Vaccine (2001) 1.47
Control of varicella: why is a two-dose schedule necessary? Pediatr Infect Dis J (2006) 1.47
Postlicensure safety surveillance for varicella vaccine. JAMA (2000) 1.44
Genetic variation of varicella-zoster virus: evidence for geographical separation of strains. J Med Virol (2003) 1.35
Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics (1987) 1.30
Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies. Am J Dis Child (1984) 1.26
Varicella vaccination in England and Wales: cost-utility analysis. Arch Dis Child (2003) 1.20
Seroprevalence of varicella-zoster virus in the German population. Vaccine (2001) 1.14
Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect (2002) 1.11
An elementary school outbreak of varicella attributed to vaccine failure: policy implications. J Infect Dis (2004) 1.09
Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment. Drugs (1999) 1.03
Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine (2004) 1.02
Epidemiology of chickenpox in Scotland: 1981 to 1998. Commun Dis Public Health (2000) 1.02
The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium). Eur J Pediatr (2002) 1.01
Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician (2000) 1.01
Child vaccination policies in Europe: a report from the Summits of Independent European Vaccination Experts. Lancet Infect Dis (2003) 1.01
A cost benefit analysis of routine varicella vaccination in Spain. Vaccine (1999) 1.01
Complications of varicella in a defined central European population. Arch Dis Child (1998) 1.01
Assessment of varicella underreporting in Italy. Epidemiol Infect (2002) 1.01
Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children. Pediatr Infect Dis J (2006) 1.00
The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France. Vaccine (1999) 0.98
The cost-effectiveness of routine childhood varicella vaccination in Germany. Vaccine (2003) 0.96
Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J (2005) 0.96
Treatment with acyclovir of varicella pneumonia in pregnancy. Chest (1991) 0.95
Varicella zoster virus vaccination policies and surveillance strategies in Europe. Euro Surveill (2005) 0.94
Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy. J Clin Pathol (2002) 0.93
The seroepidemiology of varicella in Italy. Epidemiol Infect (2001) 0.92
Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine (2000) 0.90
Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine (2001) 0.90
Associations of daycare and school entry vaccination requirements with varicella immunization rates. Vaccine (2005) 0.89
Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group. Vaccine (1995) 0.86
Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine (2000) 0.86
[Incidence of herpes zoster in pediatricians and history of reexposure to varicella-zoster virus in patients with herpes zoster]. Kansenshogaku Zasshi (1995) 0.83
Varicella seroprevalence in a random sample of the Turkish population. Vaccine (2002) 0.81
Serotesting versus presumptive varicella vaccination of adolescents with a negative or uncertain history of chickenpox. J Adolesc Health (2001) 0.81
Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia. Epidemiol Infect (2003) 0.80
Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment. JAMA (1985) 0.80
Varicella vaccination for healthcare workers. BMJ (2005) 0.78
The varicella vaccine. Clinical trials in immunocompromised individuals. Infect Dis Clin North Am (1996) 0.78
The utility of serologic testing for varicella in an adolescent population. Vaccine (2002) 0.75
Varicella-zoster immune globulin for the prevention of chickenpox. Recommendations of the Immunization Practices Advisory Committee, Centers for Disease Control. Ann Intern Med (1984) 0.75
Pyogenic bacterial infections in humans with MyD88 deficiency. Science (2008) 4.92
Recommendations for the management of herpes zoster. Clin Infect Dis (2007) 4.33
Outbreak of varicella at a day-care center despite vaccination. N Engl J Med (2002) 4.19
Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology (2010) 4.18
Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog (2008) 4.05
Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect Dis (2010) 3.87
Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med (2015) 3.75
Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study. J Clin Microbiol (1999) 3.56
Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA (2009) 3.32
Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis (2008) 3.05
Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis (2009) 2.99
Slow initial β-lactam infusion and oral paracetamol to treat childhood bacterial meningitis: a randomised, controlled trial. Lancet Infect Dis (2011) 2.90
Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol (2010) 2.74
The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ (2005) 2.52
Acute asthma in adults: a review. Chest (2004) 2.51
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) (2010) 2.26
Topical anesthesia: possible risk factor for endophthalmitis after cataract extraction. J Cataract Refract Surg (2007) 2.23
Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts. Eur J Pediatr (2005) 2.20
Pertussis in adults: frequency of transmission after household exposure. Lancet (1995) 2.16
Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ (2008) 2.16
Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis (2006) 2.06
In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species. Eur J Clin Microbiol Infect Dis (1990) 2.06
Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics (2002) 2.03
Potential role of human challenge studies for investigation of influenza transmission. Lancet Infect Dis (2011) 1.98
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol (2010) 1.96
Prevention of influenza at Hajj: applications for mass gatherings. J R Soc Med (2013) 1.95
PEPtalk: postexposure prophylaxis against varicella in children with cancer. Arch Dis Child (2011) 1.91
Herpes zoster. BMJ (2007) 1.91
Outcome of mechanically ventilated patients who require a tracheostomy. Crit Care Med (2005) 1.91
Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis (2011) 1.89
Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J Virol (2002) 1.87
Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. Lancet Neurol (2012) 1.85
Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis (2002) 1.81
Specific capture and whole-genome sequencing of viruses from clinical samples. PLoS One (2011) 1.78
Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions. Int J Technol Assess Health Care (2011) 1.71
Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch Pediatr Adolesc Med (2008) 1.70
Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics (2001) 1.67
Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J Invest Dermatol (2002) 1.66
IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients. Blood (2012) 1.65
Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology (2012) 1.65
Varicella vaccination in Europe - taking the practical approach. BMC Med (2009) 1.63
Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J (2002) 1.63
The burden of Herpes Zoster: a prospective population based study. Vaccine (2005) 1.61
The prevention and management of herpes zoster. Med J Aust (2008) 1.60
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis (2002) 1.58
Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis. J Clin Microbiol (2005) 1.56
A study of shingles and the development of postherpetic neuralgia in East London. J Med Virol (2003) 1.55
Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J (2006) 1.54
Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children. Eur J Clin Microbiol Infect Dis (1999) 1.52
Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial. Clin Infect Dis (2010) 1.51
Use of helium-oxygen mixtures in the treatment of acute asthma: a systematic review. Chest (2003) 1.50
Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol (2003) 1.48
Antibiotic treatment of acute otorrhea through tympanostomy tube: randomized double-blind placebo-controlled study with daily follow-up. Pediatrics (2003) 1.47
Hajj: health lessons for mass gatherings. J Infect Public Health (2008) 1.46
The burden of influenza in children. Curr Opin Infect Dis (2007) 1.44
Prognostic accuracy of five simple scales in childhood bacterial meningitis. Scand J Infect Dis (2012) 1.44
One year of Neisseria gonorrhoeae isolates in Sweden: the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure. Int J STD AIDS (2002) 1.44
Anaphylaxis as an adverse event following immunisation in the UK and Ireland. Arch Dis Child (2012) 1.42
Long-term immunological follow-up of children with haemophilus influenzae serotype b vaccine failure in the United Kingdom. Clin Infect Dis (2009) 1.42
Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis (2008) 1.41
Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis (2005) 1.39
[Community-acquired methicillin-resistant Staphylococcus aureus infections in children]. Enferm Infecc Microbiol Clin (2010) 1.39
Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol (2005) 1.38
[Patient characteristics and health care burden during the influenza A (H1N1) 2009 pandemic in the university Hospital Vall d'Hebron of Barcelona]. Enferm Infecc Microbiol Clin (2011) 1.38
[Susceptibility to varicella among health care workers. Acceptability and response to vaccination]. Med Clin (Barc) (2011) 1.38
Pericarditis after meningococcal infection: case report of a child with two distinct episodes. Pediatr Infect Dis J (2004) 1.38
The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J (2009) 1.37
Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom. Infect Immun (2003) 1.36
Cost-effectiveness of influenza vaccination of healthy children. Vaccine (2006) 1.36
Measles in the United States during the postelimination era. J Infect Dis (2010) 1.36
Seasonality of respiratory syncytial virus-positive hospitalizations in children in Kiel, Germany, over a 7-year period. Infection (2002) 1.35
Ethnicity, social deprivation and psychological distress in adolescents: school-based epidemiological study in east London. Br J Psychiatry (2004) 1.35
Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial. Vaccine (2008) 1.35
Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status. Eur J Immunol (2006) 1.34
Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children. J Infect Dis (2007) 1.31
Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the porB gene confirms presence of two circulating strains. J Clin Microbiol (2002) 1.30
Influenza among U.K. pilgrims to hajj, 2003. Emerg Infect Dis (2004) 1.29
Detection of delayed vaccinations: a new approach to visualize vaccine uptake. Epidemiol Infect (2002) 1.28
Acute neurologic illness of unknown etiology in children - Colorado, August-September 2014. MMWR Morb Mortal Wkly Rep (2014) 1.27
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. Clin Infect Dis (2008) 1.26
Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J (2003) 1.26
Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009. Influenza Other Respir Viruses (2011) 1.24
Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain. J Clin Microbiol (2006) 1.23
Toward a quantitative DNA-based definition of pneumococcal pneumonia: a comparison of Streptococcus pneumoniae target genes, with special reference to the Spn9802 fragment. Diagn Microbiol Infect Dis (2007) 1.23
CSF shunt infections in children. Infection (1993) 1.22
Prevention of pandemic influenza after mass gatherings - learning from Hajj. J R Soc Med (2010) 1.22
Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis (2000) 1.22
Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ (2006) 1.21
The Swedish new variant of Chlamydia trachomatis: genome sequence, morphology, cell tropism and phenotypic characterization. Microbiology (2010) 1.21
Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study. J Infect Dis (2011) 1.20
Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens. Vaccine (2005) 1.19